FDA accepted NDA for zidesamtinib for the treatment of TKI pre-treated patients with advanced ROS1-positive NSCLC; PDUFA target action date of September 18, 2026 NDA submission for neladalkib in TKI ...

While generative AI has helped unlock creativity, agentic AI is now unlocking autonomy. However, the real transformation lies not in the technology, but in how enterprises design for it. As ...

The New York Times revealed that Chinese dictator Xi Jinping harbors fear that the United States might design a disease to target him personally in an editorial published on Tuesday. “The purpose, the ...

As organizations accelerate AI adoption and expand analytics capabilities, many still struggle to execute their data strategies due to unclear operating models, siloed decision-making, and ...

The firm's new blueprint, Establish the Target Operating Model Needed to Execute Your Data Strategy, provides data and IT leaders with a negotiation-first, principle-driven framework to align ...